Estratest

WikiDoc Resources for Estratest
Articles
Most recent articles on Estratest Most cited articles on Estratest Review articles on Estratest Articles on Estratest in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Estratest Images of Estratest Photos of Estratest Podcasts & MP3s on Estratest Videos on Estratest
Evidence Based Medicine
Cochrane Collaboration on Estratest Bandolier on Estratest TRIP on Estratest
Clinical Trials
Ongoing Trials on Estratest at Clinical Trials.gov Trial results on Estratest Clinical Trials on Estratest at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Estratest NICE Guidance on Estratest NHS PRODIGY Guidance FDA on Estratest CDC on Estratest
Books
Books on Estratest
News
Estratest in the news Be alerted to news on Estratest News trends on Estratest
Commentary
Blogs on Estratest
Definitions
Definitions of Estratest
Patient Resources / Community
Patient resources on Estratest Discussion groups on Estratest Patient Handouts on Estratest Directions to Hospitals Treating Estratest Risk calculators and risk factors for Estratest
Healthcare Provider Resources
Symptoms of Estratest Causes & Risk Factors for Estratest Diagnostic studies for Estratest Treatment of Estratest
Continuing Medical Education (CME)
CME Programs on Estratest
International
Estratest en Espanol Estratest en Francais
Business
Estratest in the Marketplace Patents on Estratest
Experimental / Informatics
List of terms related to Estratest

Estratest is hormone replacement therapy drug that combines esterified estrogens with methyltestosterone in one pill.

Indications

Estratest is used to treat menopausal women who suffer from hot flashes but do not get relief from estrogen-only therapy

History

Estratest was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical company Solvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the FDA.

Solvay is currently sponsoring a clinical trial of Estratest in the United States to determine whether the product is superior to treatment with esterified estrogens tablets

Dosage

Estratest is sold in tablet form, with either 1.25 mg estrogens/2.5 mg methyltestosterone or 0.625 mg estrogens/1.25 mg methyltestosterone available.

Supply

Estratest is supplied by Solvay.

Reference

• August 2003 press release from the Prescription Access Litigation project [1].

External links

• The product's web site
• The clinical trial site